MURA Mural Oncology plc: Company Short-Term Debts

Symbol and logo of brand Mural Bio (MURA)

Mural Oncology plc (MURA) maintains high operational efficiency through the optimization of international biomaterial supply chains. Current borrowed funds on the GURU.Markets daily price chart illustrate liability dynamics, where the 0.00 mark reflects the latest data. The development strategy relies on outsourcing clinical trials to advance immunotherapy, while the readiness of partner plants ensures the seamless scaling of mass drug production.

MURA muraloncology.com Company Short-Term Loans and Borrowings (02/21/2024 - 12/20/2025)

MURA (Mural Oncology PLC): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Mural Bio|MURA - Consensus Target
- company stock capitalization data:
Market Capitalization Mural Oncology plc|MURA - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Mural Oncology|MURA - Accounting Value of Company|Market Cap to Net Assets Ratio muraloncology.com|MURA - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Mural Oncology plc|MURA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Mural Bio|MURA - Company Aggregate Debts|Debt to Book Capitalization Ratio Mural Oncology plc|MURA - Company Long-Term Loans and Borrowings|Company Short-Term Debts Mural Oncology|Quick Liquidity muraloncology.com
- earnings and multiples data:
MURA - Net Income
Analysis of all company metrics:MURA - muraloncology.com
Manufactured products of Mural Oncology plc

Geopolitical barriers and reagent shortages are slowing clinical trials at Mural Oncology plc (MURA), increasing the risk of operational downtime. Under these conditions, the volume of short-term liabilities measures the total debt maturing within one year, determining the company's ability to maintain liquidity without emergency capital raises. Analyzing this metric allows investors to assess business resilience to turbulence and avoid assets under critical credit pressure.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|Company Current Liabilities tuhurabio.com HURA|Protara Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Fate Therapeutics Inc FATE|WHWK - Company Short-Term Debt|Company Short-Term Loans and Borrowings TCRX (TScan Therapeutics)|CSBR: Company Short-Term Debts|XBiotech (XBIT) - Company Short-Term Debts|Company Short-Term Debt CEL-SCI Corp.|Company Short-Term Debt OSTX|Company Current Liabilities RADX (Radiopharm Theranostics)|ARTV (artivabio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Adlai Nortye ANL|verupharma.com (VERU) - Short-Term Debt|TPST - Company Short-Term Debt|XLO (Xilio Therapeutics, Inc.) - Company Short-Term Indebtedness|RENB: Company Short-Term Debts|Company Current Liabilities Kairos Pharma|Company Short-Term Debt OnKure Therapeutics, Inc.|Short-Term Debt CytoMed GDTC|Company Short-Term Debt Curis, Inc. (CRIS)|Company Short-Term Debt APLM (apollomicsinc.com)|Company Short-Term Debt Tharimmune Corp THAR|Advanced Biomed Inc. (ADVB) - Short-Term Debt|Genprex, Inc. - Company Short-Term Debts|Short-Term Indebtedness Calidi Biotherapeutics (CLDI)|SBFM (Sunshine Biopharma) - Company Current Liabilities|Short-Term Debt Xenetic Biosciences, Inc. (XBIO)|Company Current Liabilities SLRX|PPBT: Company Short-Term Loans and Borrowings|Company Short-Term Debt American Oncology Network (AONC)|BGNE: Current Liabilities|Company Short-Term Debt Checkpoint Therapeutics, Inc. CKPT|Elevation Oncology Inc. - Company Short-Term Debt|iCAD Corp - Company Short-Term Debts|Ikena Oncology, Inc. (IKNA) - Company Current Liabilities|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|Company Current Liabilities Viracta Therapeutics, Inc.|Company Current Liabilities MOR|Company Short-Term Debts NAYA Biosciences Inc|Company Short-Term Debt Ascentage Pharma Group Ltd (AAPGV)